Semaglutide is a compounded Bioidentical formulation of GLP-1
Calocurb recommends gradually increasing your dose over several days can help ease any initial discomfort
For teenagers and young adults under 21 with severe injuries that have failed conventional treatment, REGEN might be considered under medical supervision
In December 2025, Lupin entered an exclusive licensing, supply and distribution agreement with Gan & Lee Pharmaceuticals for Bofanglutide, a novel fortnightly injectable GLP-1 agonist
Lantus delivers 100 units per milliliter (U-100), while Toujeo packs three times that amount into the same volume
Jennie Stanford, an expert in obesity medicine, highlights that as we age, the likelihood of developing various health issues increases